Table 3 |
||||||
|
mRNA expression level of several markers associates with neuroblastoma risk factors, prognostic groups and survival |
||||||
|
Grouping variable |
Statistics |
CNR1 |
GRB10 |
KRT19 |
PRPH |
QPCT |
|
|
||||||
|
Stage |
Kruskal-Wallis P-value |
<0.001 |
0.008 |
0.118 |
0.010 |
<0.001 |
|
MYCN |
Mann-Whitney P-value |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
|
Age cutoff 12 months |
Mann-Whitney P-value |
<0.001 |
0.609 |
<0.001 |
0.005 |
<0.001 |
|
Age cutoff 18 months |
Mann-Whitney P-value |
<0.001 |
0.810 |
<0.001 |
0.003 |
0.006 |
|
Overall survival status |
Mann-Whitney P-value |
<0.001 |
0.003 |
0.023 |
<0.001 |
<0.001 |
|
Prognostic group |
Kruskal-Wallis P-value |
<0.001 |
0.002 |
0.005 |
<0.001 |
<0.001 |
|
|
||||||
|
The statistical test used is shown and P-values (corrected for multiple testing using Benjamini-Hochberg) are indicated. P-values in bold indicate significant associations. |
||||||
|
Decock et al. Genome Biology 2012 13:R95 doi:10.1186/gb-2012-13-10-r95 |
||||||